select a format
Recent Viewed Reports
Why Ken Reasearch?
This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"
I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"
While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"
We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"
The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"
KENCB10 - Avail a discount of 10% and cash back of 10% on all publications. Applicable on all licenses. Not Applicable on Ken Research Publications Limited Time Period Offer T&C apply
• Promo code can be used 1 time per user
Ambryx Biotechnology, Inc.-Product Pipeline Review-2015
Global Markets Direct's, 'Ambryx Biotechnology, Inc.-Product Pipeline Review-2015', provides an overview of the Ambryx Biotechnology, Inc.'s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Ambryx Biotechnology, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
The report provides brief overview of Ambryx Biotechnology, Inc. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Ambryx Biotechnology, Inc.'s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Ambryx Biotechnology, Inc.'s pipeline products
Reasons To Buy
Evaluate Ambryx Biotechnology, Inc.'s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Ambryx Biotechnology, Inc. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Ambryx Biotechnology, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Ambryx Biotechnology, Inc. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ambryx Biotechnology, Inc.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Ambryx Biotechnology, Inc. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Ambryx Biotechnology, Inc. Snapshot 4
Ambryx Biotechnology, Inc. Overview 4
Key Information 4
Key Facts 4
Ambryx Biotechnology, Inc.-Research and Development Overview 5
Key Therapeutic Areas 5
Ambryx Biotechnology, Inc.-Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products-Monotherapy 8
Ambryx Biotechnology, Inc.-Pipeline Products Glance 9
Ambryx Biotechnology, Inc.-Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Ambryx Biotechnology, Inc.-Drug Profiles 10
Product Description 10
Mechanism of Action 10
R&D Progress 10
Product Description 11
Mechanism of Action 11
R&D Progress 11
Product Description 12
Mechanism of Action 12
R&D Progress 12
Ambryx Biotechnology, Inc.-Pipeline Analysis 13
Ambryx Biotechnology, Inc.-Pipeline Products by Molecule Type 13
Ambryx Biotechnology, Inc.-Locations And Subsidiaries 14
Head Office 14
Secondary Research 15
Primary Research 15
Expert Panel Validation 15
Contact Us 15
List of Tables
Ambryx Biotechnology, Inc., Key Information 4
Ambryx Biotechnology, Inc., Key Facts 4
Ambryx Biotechnology, Inc.-Pipeline by Indication, 2015 6
Ambryx Biotechnology, Inc.-Pipeline by Stage of Development, 2015 7
Ambryx Biotechnology, Inc.-Monotherapy Products in Pipeline, 2015 8
Ambryx Biotechnology, Inc.-Preclinical, 2015 9
Ambryx Biotechnology, Inc.-Pipeline by Molecule Type, 2015 13
List of Figures
Ambryx Biotechnology, Inc.-Pipeline by Top 10 Indication, 2015 6
Single User License:
Corporate User License:
Current R&D Portfolio of Ambryx Biotechnology, Inc.; Ambryx Biotechnology, Inc. - Key Therapeutics; Ambryx Biotechnology, Inc. - Pipeline Overview and Promising Molecules; Ambryx Biotechnology, Inc. - News; Ambryx Biotechnology, Inc. - Latest Updates; Ambryx Biotechnology, Inc. - Pipeline; Ambryx Biotechnology, Inc. - Discontinued/Dormant Projects